Reduced inflammatory response under candesartan pre-treatment following transient focal ischemia in rats
Ontology highlight
ABSTRACT: Large clinical studies have shown that AT1 receptor blockers (ARBs) reduce the incidence of stroke in patients at risk. However, there is controversy about the underlying pathomechanisms. To get a closer insight into the effects of ARBs in stroke on molecular level, gene expression pattern was compared in the ischemic brain areas of Candesartan pre-treated (0,2 mg/kg bwt., 5 days, s.c.) versus vehicle treated, normotensive, adult rats after middle carotid artery occlusion (MCAO). Candesartan significantly improved neurological outcome (as estimated by Garcia-scale) 24 h and 48 h after stroke and reduced infarct volume by about 40% compared to vehicle. Keywords: disease state analysis
ORGANISM(S): Rattus norvegicus
PROVIDER: GSE4206 | GEO | 2006/12/31
SECONDARY ACCESSION(S): PRJNA95063
REPOSITORIES: GEO
ACCESS DATA